Uptake of 2-β- d-ribofuranosylthiazole-4-carboxamide (Tiazofurin) and analogues by the facilitated transport mechanism of erythrocytes
Tiazofurin (TR), a new antitumor agent, enters human erythrocytes by utilizing their facilitated nucleoside transport system. TR competes with endogenous nucleosides for this transport mechanism, thereby reducing nucleoside uptake into the cells. Pre-incubation of erythrocytes for 10 min at 22°C wit...
Gespeichert in:
Veröffentlicht in: | Cancer letters 1985-08, Vol.28 (1), p.1-8 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Tiazofurin (TR), a new antitumor agent, enters human erythrocytes by utilizing their facilitated nucleoside transport system. TR competes with endogenous nucleosides for this transport mechanism, thereby reducing nucleoside uptake into the cells. Pre-incubation of erythrocytes for 10 min at 22°C with 100 μM and 500 μM TR reduced the transport of
14C-uridine into the cells by 27% and 74%, respectively. Simultaneous exposure of cells to TR and [
14C]uridine did not alter the inhibitory effect of TR. Furthermore, the transport inhibitory effect of TR was lost when cells were washed twice with Hanks basal salt solution following a 10-min pre-incubation with TR. The
K
m
and
V
max (±S.E.) for radiolabeled TR transport into erythrocytes are 170 ± 26 μM and 55 ± 13 nmol/h per 10
6 cells, respectively, which is similar to the kinetic constants measured for uridine transport into erythrocytes (
K
m
= 168 ± 37
μM and
V
max = 61 ± 16 nmol/h per 10
6 cells). The
K
i
(±S.E.) of TR for uridine transport is 178 ± 11 μM and for thymidine transport is 102 ± 59 μM. Three analogues of TR (its selenium isostere (SR), and Ara (Ara-TR) and Xylo (Xylo-TR) derivatives) were compared with TR for their ability to compete with and inhibit uridine transport, as these analogues were not available in a radiolabeled form for direct measurement of their transport into the cell. SR had similar kinetic characteristics of inhibition of uridine transport to TR (
K
i
= 145 ± 15
μM) but Ara-TR had a
K
i
= 1.04 ± 0.13 mM while Xylo-TR inhibited uridine transport with a
K
i
= 1.57 ± 0.67 mM. Thus, TR is transported into erythrocytes with the same velocity and affinity for the carrier as uridine and competitively inhibits nucleoside transport into the cell. Of 3 other C-nucleoside derivatives examined, SR is of similar potency to TR but Ara-TR and Xylo-TR are much less effective at competing with uridine for the nucleoside transporter. |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/0304-3835(85)90085-0 |